Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Prins

Showing results (81-90 of 153) with videos related to

Pageof 16
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)|August 8, 2024
Pooling Alzheimer's disease clinical trial data to develop personalized medicine approaches is easier said than done: A proof-of-principle study and call to actionMark A Dubbelman, Eleonora M Vromen, Betty M Tijms, et al.
Alzheimer'S Research & Therapy|August 24, 2021
Rationale and study design of a randomized, placebo-controlled, double-blind phase 2b trial to evaluate efficacy, safety, and tolerability of an oral glutaminyl cyclase inhibitor varoglutamstat (PQ912) in study participants with MCI and mild AD-VIVIADE G B Vijverberg, T M Axelsen, A R Bihlet, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentLieza G Exalto, Siti S Syaziyah, Xiaotian T Fang, et al.
The Journal of Prevention of Alzheimer'S Disease|May 8, 2026
Top five Alzheimer Disease trial eligibility criteria favor men compared to women in a clinic-based cohortLieza G Exalto, Siti S Syaziyah, Xiaotian T Fang, et al.
Journal of Alzheimer'S Disease : JAD|February 1, 2013
Associations between magnetic resonance imaging measures and neuropsychological impairment in early and late onset alzheimer's diseaseAnnelies E van der Vlies, Salka S Staekenborg, Faiza Admiraal-Behloul, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 20, 2004
Arterial oxygen saturation, COPD, and cerebral small vessel diseaseE J van Dijk, S E Vermeer, J C de Groot, et al.
Scientific Reports|November 16, 2019
Performance of five automated white matter hyperintensity segmentation methods in a multicenter datasetRutger Heinen, Martijn D Steenwijk, Frederik Barkhof, et al.
Neurobiology of Aging|July 15, 2014
Brain volume and white matter hyperintensities as determinants of cerebral blood flow in Alzheimer's diseaseMarije R Benedictus, Maja A A Binnewijzend, Joost P A Kuijer, et al.
Alzheimer'S Research & Therapy|December 29, 2019
High occurrence of transportation and logistics occupations among vascular dementia patients: an observational studyA C van Loenhoud, C de Boer, K Wols, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 30, 2015
Identifying bvFTD Within the Wide Spectrum of Late Onset Frontal Lobe Syndrome: A Clinical ApproachWelmoed A Krudop, Cora J Kerssens, Annemiek Dols, et al.
Pageof 16

Showing results (81-90 of 153) with videos related to

Sort By:
Pageof 16
Alzheimer'S & Dementia (New York, N. Y.)|August 8, 2024
Pooling Alzheimer's disease clinical trial data to develop personalized medicine approaches is easier said than done: A proof-of-principle study and call to actionMark A Dubbelman, Eleonora M Vromen, Betty M Tijms, et al.
Alzheimer'S Research & Therapy|August 24, 2021
Rationale and study design of a randomized, placebo-controlled, double-blind phase 2b trial to evaluate efficacy, safety, and tolerability of an oral glutaminyl cyclase inhibitor varoglutamstat (PQ912) in study participants with MCI and mild AD-VIVIADE G B Vijverberg, T M Axelsen, A R Bihlet, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentLieza G Exalto, Siti S Syaziyah, Xiaotian T Fang, et al.
The Journal of Prevention of Alzheimer'S Disease|May 8, 2026
Top five Alzheimer Disease trial eligibility criteria favor men compared to women in a clinic-based cohortLieza G Exalto, Siti S Syaziyah, Xiaotian T Fang, et al.
Journal of Alzheimer'S Disease : JAD|February 1, 2013
Associations between magnetic resonance imaging measures and neuropsychological impairment in early and late onset alzheimer's diseaseAnnelies E van der Vlies, Salka S Staekenborg, Faiza Admiraal-Behloul, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 20, 2004
Arterial oxygen saturation, COPD, and cerebral small vessel diseaseE J van Dijk, S E Vermeer, J C de Groot, et al.
Scientific Reports|November 16, 2019
Performance of five automated white matter hyperintensity segmentation methods in a multicenter datasetRutger Heinen, Martijn D Steenwijk, Frederik Barkhof, et al.
Neurobiology of Aging|July 15, 2014
Brain volume and white matter hyperintensities as determinants of cerebral blood flow in Alzheimer's diseaseMarije R Benedictus, Maja A A Binnewijzend, Joost P A Kuijer, et al.
Alzheimer'S Research & Therapy|December 29, 2019
High occurrence of transportation and logistics occupations among vascular dementia patients: an observational studyA C van Loenhoud, C de Boer, K Wols, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 30, 2015
Identifying bvFTD Within the Wide Spectrum of Late Onset Frontal Lobe Syndrome: A Clinical ApproachWelmoed A Krudop, Cora J Kerssens, Annemiek Dols, et al.
Pageof 16